Results 261 to 270 of about 104,823 (289)

Bevacizumab

Reactions Weekly, 2023
openaire   +1 more source

Bevacizumab

Reactions Weekly, 2013
  +4 more sources

Bevacizumab

Reactions Weekly, 2012
  +4 more sources

Bevacizumab

Reactions Weekly
  +6 more sources

Olaparib plus bevacizumab first-line maintenance in ovarian cancer: final overall survival results from the PAOLA-1/ENGOT-ov25 trial

Annals of Oncology, 2023
A Leary, J Mäenpää, E M Guerra Alia
exaly  

Bevacizumab

Reactions Weekly, 2018
openaire   +2 more sources

Bevacizumab

Reactions Weekly, 2009
openaire   +2 more sources

Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide population

European Journal of Cancer, 2023
Vera Himmelsbach, Margarida Montes, Takashi Niizeki   +2 more
exaly  

Bevacizumab

Reactions Weekly, 2016
  +4 more sources

Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study

Annals of Oncology, 2009
A Kretzschmar, J -L Canon, J Bridgewater   +2 more
exaly